Virtual Interaction With Experts: Exploring Novel Therapeutics in Acute Myeloid Leukemia

In this virtual program faculty experts explore the use of investigational immunotherapeutic agents including monoclonal antibody&ndash based therapy immune checkpoint inhibitors vaccines and adoptive cell&ndash based therapy in treating patients with AML. Management of treatment-related toxicities will also be presented.

Share

Program Content

Activities

Novel Therapeutics in AML
Virtual Interaction With Experts: Exploring Novel Therapeutics in Acute Myeloid Leukemia
Video
Congratulations: You achieved a completion on 04/09/2022

Released: September 03, 2020

Expires: September 02, 2021

Activities

SOC Tx: elderly AML pts
Standard of Care Therapy for Elderly Patients with AML in 2020
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2020

Expires: July 15, 2021

Investigational Tx in AML
Investigational Agents and Combinations for AML
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2020

Expires: July 15, 2021

Supporters

Supported by an independent grant from

Helsinn Healthcare SA